Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finke

Showing results (111-120 of 180) with videos related to

Pageof 18
Sort By:
American Journal of Hematology|June 8, 2019
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisGiacomo Coltro, Terra L Lasho, Christy M Finke, et al.
International Angiology : a Journal of the International Union of Angiology|June 15, 2000
Risk factor assessment in the management of patients with suspected deep venous thrombosisG D Motykie, J A Caprini, J I Arcelus, et al.
Biochemical and Biophysical Research Communications|January 29, 1982
Acetylcholinesterase inhibition by the ketone transition state analog phenoxyacetone and 1-halo-3-phenoxy-2-propanonesA Dafforn, J P Neenan, C E Ash, et al.
Radiation Research|March 11, 2011
Effects of external beam radiation on in vitro formation of Abeta1-42 fibrils and preformed fibrilsLynnae M Patrias, Andrea C Klaver, Mary P Coffey, et al.
European Journal of Haematology|December 18, 2007
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlatesNaseema Gangat, Jacob Strand, Terra L Lasho, et al.
American Journal of Hematology|March 18, 2017
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
American Journal of Hematology|December 6, 2018
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patientsDomenico Penna, Terra L Lasho, Christy M Finke, et al.
Leukemia|January 10, 2014
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisonsA Tefferi, T L Lasho, C M Finke, et al.
Leukemia|May 4, 2007
Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia veraA Tefferi, J J Strand, T L Lasho, et al.
Leukemia|October 29, 2011
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patientsM M Patnaik, C A Hanson, J M Hodnefield, et al.
Pageof 18

Showing results (111-120 of 180) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|June 8, 2019
Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosisGiacomo Coltro, Terra L Lasho, Christy M Finke, et al.
International Angiology : a Journal of the International Union of Angiology|June 15, 2000
Risk factor assessment in the management of patients with suspected deep venous thrombosisG D Motykie, J A Caprini, J I Arcelus, et al.
Biochemical and Biophysical Research Communications|January 29, 1982
Acetylcholinesterase inhibition by the ketone transition state analog phenoxyacetone and 1-halo-3-phenoxy-2-propanonesA Dafforn, J P Neenan, C E Ash, et al.
Radiation Research|March 11, 2011
Effects of external beam radiation on in vitro formation of Abeta1-42 fibrils and preformed fibrilsLynnae M Patrias, Andrea C Klaver, Mary P Coffey, et al.
European Journal of Haematology|December 18, 2007
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlatesNaseema Gangat, Jacob Strand, Terra L Lasho, et al.
American Journal of Hematology|March 18, 2017
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemiaMrinal M Patnaik, Daniela Barraco, Terra L Lasho, et al.
American Journal of Hematology|December 6, 2018
20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patientsDomenico Penna, Terra L Lasho, Christy M Finke, et al.
Leukemia|January 10, 2014
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisonsA Tefferi, T L Lasho, C M Finke, et al.
Leukemia|May 4, 2007
Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia veraA Tefferi, J J Strand, T L Lasho, et al.
Leukemia|October 29, 2011
Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patientsM M Patnaik, C A Hanson, J M Hodnefield, et al.
Pageof 18